NLRX1 Protein Attenuates Inflammatory Responses to Infection by Interfering with the RIG-I-MAVS and TRAF6-NF-κB Signaling Pathways

The nucleotide-binding domain and leucine-rich-repeat-containing (NLR) proteins regulate innate immunity. Although the positive regulatory impact of NLRs is clear, their inhibitory roles are not well defined. We showed that Nlrx1 −/− mice exhibited increased expression of antiviral signaling molecul...

Full description

Saved in:
Bibliographic Details
Published inImmunity (Cambridge, Mass.) Vol. 34; no. 6; pp. 854 - 865
Main Authors Allen, Irving C., Moore, Chris B., Schneider, Monika, Lei, Yu, Davis, Beckley K., Scull, Margaret A., Gris, Denis, Roney, Kelly E., Zimmermann, Albert G., Bowzard, John B., Ranjan, Priya, Monroe, Kathryn M., Pickles, Raymond J., Sambhara, Suryaprakash, Ting, Jenny P.Y.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 24.06.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The nucleotide-binding domain and leucine-rich-repeat-containing (NLR) proteins regulate innate immunity. Although the positive regulatory impact of NLRs is clear, their inhibitory roles are not well defined. We showed that Nlrx1 −/− mice exhibited increased expression of antiviral signaling molecules IFN-β, STAT2, OAS1, and IL-6 after influenza virus infection. Consistent with increased inflammation, Nlrx1 −/− mice exhibited marked morbidity and histopathology. Infection of these mice with an influenza strain that carries a mutated NS-1 protein, which normally prevents IFN induction by interaction with RNA and the intracellular RNA sensor RIG-I, further exacerbated IL-6 and type I IFN signaling. NLRX1 also weakened cytokine responses to the 2009 H1N1 pandemic influenza virus in human cells. Mechanistically, Nlrx1 deletion led to constitutive interaction of MAVS and RIG-I. Additionally, an inhibitory function is identified for NLRX1 during LPS activation of macrophages where the MAVS-RIG-I pathway was not involved. NLRX1 interacts with TRAF6 and inhibits NF-κB activation. Thus, NLRX1 functions as a checkpoint of overzealous inflammation. ► NLRX1 attenuates IFN induction by preventing the interaction between RIG-I and MAVS ► NLRX1 functions as a negative regulator of IFN-I and IL-6 during influenza infection ► NLRX1 attenuates inflammation by intersecting the TRAF6 pathway to affect NF-κB
AbstractList The nucleotide-binding domain and leucine-rich-repeat-containing (NLR) proteins regulate innate immunity. Although the positive regulatory impact of NLRs is clear, their inhibitory roles are not well defined. We showed that Nlrx1(-/-) mice exhibited increased expression of antiviral signaling molecules IFN-β, STAT2, OAS1, and IL-6 after influenza virus infection. Consistent with increased inflammation, Nlrx1(-/-) mice exhibited marked morbidity and histopathology. Infection of these mice with an influenza strain that carries a mutated NS-1 protein, which normally prevents IFN induction by interaction with RNA and the intracellular RNA sensor RIG-I, further exacerbated IL-6 and type I IFN signaling. NLRX1 also weakened cytokine responses to the 2009 H1N1 pandemic influenza virus in human cells. Mechanistically, Nlrx1 deletion led to constitutive interaction of MAVS and RIG-I. Additionally, an inhibitory function is identified for NLRX1 during LPS activation of macrophages where the MAVS-RIG-I pathway was not involved. NLRX1 interacts with TRAF6 and inhibits NF-κB activation. Thus, NLRX1 functions as a checkpoint of overzealous inflammation.
The nucleotide-binding domain and leucine-rich-repeat-containing (NLR) proteins regulate innate immunity. Although the positive regulatory impact of NLRs is clear, their inhibitory roles are not well defined. We showed that Nlrx1 −/− mice exhibited increased expression of antiviral signaling molecules IFN-β, STAT2, OAS1, and IL-6 after influenza virus infection. Consistent with increased inflammation, Nlrx1 −/− mice exhibited marked morbidity and histopathology. Infection of these mice with an influenza strain that carries a mutated NS-1 protein, which normally prevents IFN induction by interaction with RNA and the intracellular RNA sensor RIG-I, further exacerbated IL-6 and type I IFN signaling. NLRX1 also weakened cytokine responses to the 2009 H1N1 pandemic influenza virus in human cells. Mechanistically, Nlrx1 deletion led to constitutive interaction of MAVS and RIG-I. Additionally, an inhibitory function is identified for NLRX1 during LPS activation of macrophages where the MAVS-RIG-I pathway was not involved. NLRX1 interacts with TRAF6 and inhibits NF-κB activation. Thus, NLRX1 functions as a checkpoint of overzealous inflammation. ► NLRX1 attenuates IFN induction by preventing the interaction between RIG-I and MAVS ► NLRX1 functions as a negative regulator of IFN-I and IL-6 during influenza infection ► NLRX1 attenuates inflammation by intersecting the TRAF6 pathway to affect NF-κB
Author Sambhara, Suryaprakash
Ting, Jenny P.Y.
Zimmermann, Albert G.
Bowzard, John B.
Schneider, Monika
Ranjan, Priya
Davis, Beckley K.
Lei, Yu
Moore, Chris B.
Scull, Margaret A.
Pickles, Raymond J.
Monroe, Kathryn M.
Allen, Irving C.
Gris, Denis
Roney, Kelly E.
Author_xml – sequence: 1
  givenname: Irving C.
  surname: Allen
  fullname: Allen, Irving C.
  organization: The Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
– sequence: 2
  givenname: Chris B.
  surname: Moore
  fullname: Moore, Chris B.
  organization: Glaxosmithkline, Infectious Disease, Center for Excellence in Drug Discovery, Research Triangle Park, NC 27709, USA
– sequence: 3
  givenname: Monika
  surname: Schneider
  fullname: Schneider, Monika
  organization: Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
– sequence: 4
  givenname: Yu
  surname: Lei
  fullname: Lei, Yu
  organization: Oral Biology Program, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
– sequence: 5
  givenname: Beckley K.
  surname: Davis
  fullname: Davis, Beckley K.
  organization: The Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
– sequence: 6
  givenname: Margaret A.
  surname: Scull
  fullname: Scull, Margaret A.
  organization: Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
– sequence: 7
  givenname: Denis
  surname: Gris
  fullname: Gris, Denis
  organization: The Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
– sequence: 8
  givenname: Kelly E.
  surname: Roney
  fullname: Roney, Kelly E.
  organization: Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
– sequence: 9
  givenname: Albert G.
  surname: Zimmermann
  fullname: Zimmermann, Albert G.
  organization: The Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
– sequence: 10
  givenname: John B.
  surname: Bowzard
  fullname: Bowzard, John B.
  organization: Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
– sequence: 11
  givenname: Priya
  surname: Ranjan
  fullname: Ranjan, Priya
  organization: Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
– sequence: 12
  givenname: Kathryn M.
  surname: Monroe
  fullname: Monroe, Kathryn M.
  organization: Department of Molecular and Cell Biology, University of California, Berkley, CA 94720, USA
– sequence: 13
  givenname: Raymond J.
  surname: Pickles
  fullname: Pickles, Raymond J.
  organization: Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
– sequence: 14
  givenname: Suryaprakash
  surname: Sambhara
  fullname: Sambhara, Suryaprakash
  organization: Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
– sequence: 15
  givenname: Jenny P.Y.
  surname: Ting
  fullname: Ting, Jenny P.Y.
  email: jenny_ting@med.unc.edu
  organization: The Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21703540$$D View this record in MEDLINE/PubMed
BookMark eNp9kM1u1DAQxy1URD_gDRDyjZPDOHa-LkhLxZaVllJtC-JmOcmk61Vib22Has-8FQ_BM5FoC0dOHnt-M3_5d05OrLNIyGsOCQeev9slZhhGa5IUOE9AJJDmz8gZh6pgkpdwMteFZEXOxSk5D2EHwGVWwQtymvICRCbhjPy8Xm--c3rjXURj6SJGtKOOGOjKdr0eBh2dP9ANhr2zYXqObu5gE42ztD5Ml4i-Q2_sPX00cUvjFulmdcVW7PPi2y3VtqV3m8UyZ9dL9vvXB3pr7q3uZ_xGx-2jPoSX5Hmn-4Cvns4L8nX58e7yE1t_uVpdLtaskVBEJmQrZS1qKWSHFdQ6zwvUILo0y5DzsoKy0VpUad1y7CosoG5klza55iWWUosL8va4d-_dw4ghqsGEBvteW3RjUGUhgZc8yydSHsnGuxA8dmrvzaD9QXFQs321U0f7aravQKjJ_jT25ilgrAds_w391T0B748ATt_8YdCr0Bi0DbbGT0pV68z_E_4AEq6aKA
CitedBy_id crossref_primary_10_4049_jimmunol_1700251
crossref_primary_10_3390_ijms222111398
crossref_primary_10_1111_imm_13372
crossref_primary_10_1016_j_bbagen_2020_129839
crossref_primary_10_1152_ajplung_00362_2023
crossref_primary_10_1189_jlb_0312132
crossref_primary_10_1007_s12026_012_8317_3
crossref_primary_10_1128_JVI_03230_15
crossref_primary_10_1016_j_immuni_2012_03_002
crossref_primary_10_1016_j_dci_2018_07_016
crossref_primary_10_3389_fimmu_2019_02810
crossref_primary_10_3389_fimmu_2023_1161665
crossref_primary_10_1097_COH_0000000000000319
crossref_primary_10_4049_jimmunol_2200834
crossref_primary_10_1371_journal_ppat_1003256
crossref_primary_10_3402_pba_v2i0_18052
crossref_primary_10_1016_j_cyto_2022_156055
crossref_primary_10_1371_journal_ppat_1009220
crossref_primary_10_3389_fcell_2021_720490
crossref_primary_10_1016_j_coviro_2011_10_026
crossref_primary_10_3389_fcimb_2020_609812
crossref_primary_10_1016_j_celrep_2016_02_065
crossref_primary_10_1016_j_celrep_2016_02_064
crossref_primary_10_3390_v10040146
crossref_primary_10_3390_ijms23042372
crossref_primary_10_1016_j_it_2015_12_003
crossref_primary_10_3389_fimmu_2014_00169
crossref_primary_10_1080_08830185_2020_1800688
crossref_primary_10_1186_s11658_020_00203_2
crossref_primary_10_1016_j_immuni_2012_03_012
crossref_primary_10_1126_scisignal_adh1641
crossref_primary_10_1016_j_aquaculture_2022_739146
crossref_primary_10_1186_s13045_018_0573_9
crossref_primary_10_1016_j_cyto_2014_03_007
crossref_primary_10_1371_journal_pone_0145420
crossref_primary_10_1007_s00018_015_2123_8
crossref_primary_10_1016_j_psj_2023_103077
crossref_primary_10_1016_j_micinf_2013_03_008
crossref_primary_10_1038_cmi_2012_12
crossref_primary_10_1016_j_cell_2016_03_021
crossref_primary_10_1038_cr_2013_170
crossref_primary_10_1038_cmi_2016_58
crossref_primary_10_1158_0008_5472_CAN_19_3428
crossref_primary_10_4049_jimmunol_1900364
crossref_primary_10_1093_ecco_jcc_jjad192
crossref_primary_10_1038_s41467_017_02073_3
crossref_primary_10_3389_fimmu_2019_02714
crossref_primary_10_1016_j_cytogfr_2014_06_005
crossref_primary_10_1101_cshperspect_a033464
crossref_primary_10_1111_imm_12143
crossref_primary_10_1016_j_intimp_2020_106980
crossref_primary_10_1016_j_oraloncology_2016_08_003
crossref_primary_10_1038_nrm3479
crossref_primary_10_1016_j_immuni_2013_05_007
crossref_primary_10_1038_ni_3853
crossref_primary_10_3389_fimmu_2019_01293
crossref_primary_10_1016_j_chemosphere_2018_03_162
crossref_primary_10_18632_oncotarget_8861
crossref_primary_10_4161_viru_21864
crossref_primary_10_1002_jmv_29504
crossref_primary_10_1038_s41467_023_36629_3
crossref_primary_10_1016_j_dci_2024_105147
crossref_primary_10_1016_j_vetmic_2021_109167
crossref_primary_10_3389_fimmu_2017_00550
crossref_primary_10_1159_000363449
crossref_primary_10_1016_j_hbpd_2020_04_003
crossref_primary_10_1038_srep26299
crossref_primary_10_1038_srep29447
crossref_primary_10_3389_fnmol_2022_852243
crossref_primary_10_3389_fcell_2020_00008
crossref_primary_10_3390_pathogens13040306
crossref_primary_10_1080_19490976_2015_1116673
crossref_primary_10_1007_s00018_016_2212_3
crossref_primary_10_3389_fimmu_2021_749504
crossref_primary_10_1111_prd_12005
crossref_primary_10_1016_j_molimm_2016_06_013
crossref_primary_10_1016_j_virusres_2020_198245
crossref_primary_10_1038_ni_3097
crossref_primary_10_3390_cells8050400
crossref_primary_10_1111_febs_16298
crossref_primary_10_1128_JVI_03039_13
crossref_primary_10_1016_j_imbio_2022_152279
crossref_primary_10_1189_jlb_3RU0514_265RR
crossref_primary_10_1186_1750_2187_8_7
crossref_primary_10_1016_j_dci_2020_103944
crossref_primary_10_1261_rna_079016_121
crossref_primary_10_1074_jbc_M113_533034
crossref_primary_10_1016_j_dci_2014_04_010
crossref_primary_10_4110_in_2017_17_2_77
crossref_primary_10_1038_onc_2016_11
crossref_primary_10_1016_j_omto_2022_08_007
crossref_primary_10_1016_j_fsirep_2022_100056
crossref_primary_10_1016_j_bj_2023_100635
crossref_primary_10_2174_1573406415666181219101613
crossref_primary_10_1155_2020_1421795
crossref_primary_10_1038_s41564_017_0017_2
crossref_primary_10_1038_s41598_017_03258_y
crossref_primary_10_1016_j_antiviral_2014_05_012
crossref_primary_10_1159_000345937
crossref_primary_10_1371_journal_ppat_1006398
crossref_primary_10_1002_hep_30149
crossref_primary_10_1016_j_yexcr_2017_02_035
crossref_primary_10_3390_cells11111771
crossref_primary_10_4161_21645515_2014_979640
crossref_primary_10_1016_j_dci_2020_103612
crossref_primary_10_4046_trd_2016_79_4_207
crossref_primary_10_3389_fimmu_2021_689866
crossref_primary_10_1007_s13238_013_3902_3
crossref_primary_10_1002_jmv_28203
crossref_primary_10_1038_s41577_023_00849_x
crossref_primary_10_1016_j_jmb_2016_10_028
crossref_primary_10_1016_j_biomaterials_2021_120845
crossref_primary_10_1111_imr_12089
crossref_primary_10_1038_ncomms15676
crossref_primary_10_1097_MOG_0000000000000317
crossref_primary_10_3892_etm_2021_9640
crossref_primary_10_1007_s11010_017_3249_9
crossref_primary_10_1089_ars_2013_5347
crossref_primary_10_1016_j_bioelechem_2019_107369
crossref_primary_10_1038_nri_2015_8
crossref_primary_10_1016_j_cytogfr_2011_09_003
crossref_primary_10_1089_dna_2022_0051
crossref_primary_10_1016_j_vetmic_2021_109126
crossref_primary_10_1016_j_immuni_2013_02_013
crossref_primary_10_1038_cr_2012_53
crossref_primary_10_3389_fimmu_2017_02012
crossref_primary_10_4049_jimmunol_1601547
crossref_primary_10_1016_j_cell_2024_03_036
crossref_primary_10_1016_j_dci_2019_03_001
crossref_primary_10_3389_fmicb_2020_01990
crossref_primary_10_3390_ijms25031828
crossref_primary_10_1099_jgv_0_000401
crossref_primary_10_1038_s41423_021_00780_y
crossref_primary_10_1093_biolre_iox009
crossref_primary_10_3389_fimmu_2019_02419
crossref_primary_10_3389_fimmu_2018_02314
crossref_primary_10_1126_science_aab3145
crossref_primary_10_1002_eji_201646484
crossref_primary_10_1016_j_bbrc_2013_06_061
crossref_primary_10_1073_pnas_1322118111
crossref_primary_10_1016_j_fsi_2018_07_031
crossref_primary_10_1038_s12276_019_0333_0
crossref_primary_10_1038_srep23377
crossref_primary_10_1073_pnas_1317643111
crossref_primary_10_3390_antiox13040481
crossref_primary_10_4049_jimmunol_1300740
crossref_primary_10_1016_j_cytogfr_2014_07_001
crossref_primary_10_1002_eji_201142125
crossref_primary_10_3389_fonc_2023_1155831
crossref_primary_10_1007_s00011_018_1132_0
crossref_primary_10_3390_ijms22031301
crossref_primary_10_1111_j_1365_2567_2012_03561_x
crossref_primary_10_1128_JVI_01264_17
crossref_primary_10_1016_j_jaci_2012_03_044
crossref_primary_10_1124_pr_112_006171
crossref_primary_10_3389_fimmu_2019_02644
crossref_primary_10_3389_fimmu_2014_00327
crossref_primary_10_3389_fimmu_2018_00363
crossref_primary_10_3389_fimmu_2019_00104
crossref_primary_10_1016_j_immuni_2014_01_010
crossref_primary_10_1038_s41423_020_00602_7
crossref_primary_10_1016_j_isci_2019_06_008
crossref_primary_10_1084_jem_20161031
crossref_primary_10_1016_j_micinf_2017_09_014
crossref_primary_10_1038_cdd_2011_159
crossref_primary_10_1128_jvi_01801_23
crossref_primary_10_3389_fimmu_2020_541267
crossref_primary_10_1016_j_chom_2015_07_016
crossref_primary_10_1515_pac_2013_1026
crossref_primary_10_3389_fncel_2022_955222
crossref_primary_10_1002_jcp_27595
crossref_primary_10_1038_ni_2378
crossref_primary_10_1016_j_intimp_2024_112347
crossref_primary_10_1016_j_jprot_2011_11_034
crossref_primary_10_1152_physrev_00009_2014
crossref_primary_10_3389_fimmu_2019_02431
crossref_primary_10_1002_hep_25850
crossref_primary_10_3389_fimmu_2022_812774
crossref_primary_10_1186_s12864_023_09785_5
crossref_primary_10_1016_j_envres_2021_111225
crossref_primary_10_1177_1753425912467383
crossref_primary_10_1016_j_immuni_2024_03_012
crossref_primary_10_1002_art_37868
crossref_primary_10_1016_j_immuni_2011_06_006
crossref_primary_10_1038_cr_2016_40
crossref_primary_10_15252_embj_201796781
crossref_primary_10_1016_j_immuni_2020_03_017
crossref_primary_10_1371_journal_pone_0030612
crossref_primary_10_1016_j_bbadis_2018_03_003
crossref_primary_10_1016_j_it_2021_12_005
crossref_primary_10_1016_j_it_2015_03_005
crossref_primary_10_1016_j_bj_2023_100616
crossref_primary_10_1016_j_it_2016_07_004
crossref_primary_10_1016_j_mam_2020_100887
crossref_primary_10_1007_s00018_012_0962_0
crossref_primary_10_1074_jbc_M111_333146
crossref_primary_10_1016_j_molimm_2017_03_010
crossref_primary_10_1172_JCI71747
crossref_primary_10_3390_ijms22031316
crossref_primary_10_1016_j_it_2013_02_008
crossref_primary_10_1002_iid3_1125
crossref_primary_10_1159_000363602
crossref_primary_10_1111_imm_13291
crossref_primary_10_1038_s41577_020_0288_3
crossref_primary_10_1007_s13205_023_03518_x
crossref_primary_10_1002_JLB_2MIR0817_342R
crossref_primary_10_1016_j_immuni_2011_12_010
crossref_primary_10_4049_jimmunol_1601370
crossref_primary_10_1016_j_immuni_2011_12_018
crossref_primary_10_3390_v13040584
crossref_primary_10_1016_j_bbamcr_2013_01_010
crossref_primary_10_1111_omi_12121
crossref_primary_10_3389_fimmu_2022_882867
crossref_primary_10_1016_j_immuni_2018_10_008
crossref_primary_10_1159_000121607
crossref_primary_10_1155_2016_6373506
crossref_primary_10_1016_j_jmb_2013_10_007
crossref_primary_10_1007_s40495_017_0117_y
crossref_primary_10_1080_21691401_2023_2252477
crossref_primary_10_1016_j_taap_2018_02_007
crossref_primary_10_1371_journal_ppat_1008854
crossref_primary_10_3892_ijmm_2017_3077
crossref_primary_10_1016_j_virusres_2019_05_011
crossref_primary_10_3389_fnut_2020_606378
crossref_primary_10_1002_eji_201344412
crossref_primary_10_3390_v12070755
crossref_primary_10_1016_j_micinf_2012_06_005
crossref_primary_10_1016_j_neulet_2015_11_053
crossref_primary_10_1002_JLB_3MIR0817_346RRR
crossref_primary_10_1371_journal_pone_0098899
crossref_primary_10_1038_ncomms13882
crossref_primary_10_12688_f1000research_15361_3
crossref_primary_10_1128_jvi_01434_23
crossref_primary_10_12688_f1000research_15361_2
crossref_primary_10_12688_f1000research_15361_1
crossref_primary_10_1186_s12974_020_01764_x
crossref_primary_10_4049_jimmunol_2290008
crossref_primary_10_1111_aji_12687
crossref_primary_10_1016_j_cyto_2013_05_007
crossref_primary_10_1016_j_immuni_2012_03_025
crossref_primary_10_1016_j_jdiacomp_2017_08_013
crossref_primary_10_1177_1534734618794856
crossref_primary_10_1038_s41380_023_02189_7
crossref_primary_10_3389_fimmu_2022_882521
crossref_primary_10_3389_fimmu_2020_591815
crossref_primary_10_1007_s12011_021_03042_0
crossref_primary_10_1038_icb_2013_7
crossref_primary_10_1016_j_jot_2017_05_004
crossref_primary_10_3390_v11020099
crossref_primary_10_1016_j_chom_2016_03_001
crossref_primary_10_1089_jir_2011_0092
crossref_primary_10_1159_000441299
crossref_primary_10_1186_s12985_015_0284_6
crossref_primary_10_1016_j_ejphar_2020_173276
crossref_primary_10_1371_journal_pntd_0001936
crossref_primary_10_3390_v8100269
crossref_primary_10_1371_journal_pone_0137839
crossref_primary_10_1016_j_bbamcr_2012_03_005
crossref_primary_10_1084_jem_20181832
crossref_primary_10_1007_s00018_021_03887_7
crossref_primary_10_1016_j_intimp_2017_09_010
crossref_primary_10_1002_art_39733
crossref_primary_10_1016_j_fsi_2016_04_126
crossref_primary_10_2174_1573395514666180605082507
crossref_primary_10_3390_pathogens12111373
crossref_primary_10_1016_j_chom_2016_03_011
crossref_primary_10_1016_j_fsi_2018_03_009
crossref_primary_10_3389_fimmu_2018_02761
crossref_primary_10_1016_j_ijbiomac_2020_12_127
crossref_primary_10_1097_MIB_0000000000000151
crossref_primary_10_1186_s13041_014_0090_x
crossref_primary_10_1016_j_intimp_2019_03_001
crossref_primary_10_4049_jimmunol_1302632
crossref_primary_10_3390_ijms140918124
crossref_primary_10_1038_s41590_021_00898_1
crossref_primary_10_3389_fimmu_2023_1257192
Cites_doi 10.4049/jimmunol.178.10.6444
10.1016/j.immuni.2011.02.022
10.1126/scisignal.2000287
10.1165/rcmb.2006-0283RC
10.1016/j.immuni.2006.04.004
10.1074/jbc.M110.109736
10.1073/pnas.0811029106
10.1038/nature06501
10.1038/ni1243
10.1080/01926230701302558
10.1016/j.cell.2005.08.012
10.4049/jimmunol.0900557
10.1016/j.cell.2010.01.020
10.4049/jimmunol.0903900
10.4049/jimmunol.0901646
10.1038/nature04734
10.1128/JVI.01856-06
10.1073/pnas.0704014104
10.1038/ni.1815
10.1128/JVI.74.3.1513-1523.2000
10.1074/jbc.M502820200
10.1016/j.immuni.2009.02.006
10.1074/jbc.M110.137885
10.1126/science.1132998
10.1152/ajpcell.00120.2007
10.1038/sj.embor.7401161
10.1128/JVI.01325-06
10.4049/jimmunol.178.3.1256
10.1016/j.immuni.2009.02.005
10.4049/jimmunol.178.6.3368
10.1016/j.cell.2010.03.040
10.1016/j.immuni.2005.04.010
10.1038/ni.1782
ContentType Journal Article
Copyright 2011 Elsevier Inc.
Copyright © 2011 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2011 Elsevier Inc.
– notice: Copyright © 2011 Elsevier Inc. All rights reserved.
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.immuni.2011.03.026
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1097-4180
EndPage 865
ExternalDocumentID 10_1016_j_immuni_2011_03_026
21703540
S1074761311002263
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: F32 AI082895
– fundername: NIAID NIH HHS
  grantid: U54-AI057157
– fundername: NIAID NIH HHS
  grantid: F32 AI082895-01
– fundername: NIAID NIH HHS
  grantid: U54 AI057157
– fundername: NCI NIH HHS
  grantid: T32-CA009156
– fundername: NIAMS NIH HHS
  grantid: T32-AR007416
– fundername: NIAID NIH HHS
  grantid: U19 AI077437
– fundername: NIAID NIH HHS
  grantid: U19 AI067798
– fundername: NCI NIH HHS
  grantid: R01 CA156330
– fundername: NIAID NIH HHS
  grantid: U19-AI077437
GroupedDBID ---
--K
-DZ
.55
.GJ
0R~
1RT
1~5
29I
2WC
3V.
4.4
457
4G.
53G
5GY
5VS
62-
6I.
7-5
7RV
7X7
8C1
8FE
8FH
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKRW
AALRI
AAQFI
AAQXK
AAUCE
AAVLU
AAXJY
AAXUO
ABMAC
ABMWF
ABOCM
ABVKL
ACGFO
ACGFS
ACIWK
ACPRK
ADBBV
ADEZE
ADFRT
ADJPV
ADMUD
AEFWE
AENEX
AEXQZ
AFKRA
AFRAH
AFTJW
AGGSO
AGHFR
AGKMS
AHHHB
AHMBA
AHPSJ
AITUG
ALKID
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
BAWUL
BBNVY
BENPR
BHPHI
BKEYQ
BPHCQ
BVXVI
C45
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FCP
FDB
FEDTE
FGOYB
FIRID
G-2
HCIFZ
HVGLF
HZ~
IH2
IHE
IXB
J1W
JIG
LK8
LX5
M2O
M3Z
M41
M7P
N9A
NCXOZ
O-L
O9-
OHT
OK1
OVD
OZT
P2P
PQQKQ
PROAC
R2-
RCE
RIG
ROL
RPZ
SCP
SES
SSZ
TEORI
TR2
UHS
WQ6
X7M
Y6R
ZA5
ZGI
0SF
AAMRU
ADVLN
AKAPO
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ACRPL
ADNMO
CITATION
7X8
ID FETCH-LOGICAL-c407t-34d44b3b434fe90ba667ea03f255e118908caa392bd1ef9e70bc4f2c6a18e84a3
IEDL.DBID ABVKL
ISSN 1074-7613
IngestDate Fri Oct 25 04:05:56 EDT 2024
Fri Dec 06 02:59:16 EST 2024
Sat Sep 28 07:48:38 EDT 2024
Fri Feb 23 02:28:42 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
Copyright © 2011 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c407t-34d44b3b434fe90ba667ea03f255e118908caa392bd1ef9e70bc4f2c6a18e84a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1074761311002263
PMID 21703540
PQID 874018156
PQPubID 23479
PageCount 12
ParticipantIDs proquest_miscellaneous_874018156
crossref_primary_10_1016_j_immuni_2011_03_026
pubmed_primary_21703540
elsevier_sciencedirect_doi_10_1016_j_immuni_2011_03_026
PublicationCentury 2000
PublicationDate 2011-06-24
PublicationDateYYYYMMDD 2011-06-24
PublicationDate_xml – month: 06
  year: 2011
  text: 2011-06-24
  day: 24
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Immunity (Cambridge, Mass.)
PublicationTitleAlternate Immunity
PublicationYear 2011
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Yasukawa, Oshiumi, Takeda, Ishihara, Yanagi, Seya, Kawabata, Koshiba (bib32) 2009; 2
Guo, Chen, Zeng, Gomez, Plowden, Fujita, Katz, Donis, Sambhara (bib7) 2007; 36
Sabbah, Chang, Harnack, Frohlich, Tominaga, Dube, Xiang, Bose (bib23) 2009; 10
Cui, Zhu, Xia, Wang, Legras, Hong, Ji, Shen, Zheng, Chen, Wang (bib6) 2010; 141
Kuenzel, Till, Winkler, Häsler, Lipinski, Jung, Grötzinger, Fickenscher, Schreiber, Rosenstiel (bib15) 2010; 184
Williams, Lich, Duncan, Reed, Rallabhandi, Moore, Kurtz, Coffield, Accavitti-Loper, Su (bib29) 2005; 280
Neerincx, Lautz, Menning, Kremmer, Zigrino, Hösel, Büning, Schwarzenbacher, Kufer (bib20) 2010; 285
You, Sun, Zhou, Sun, Liang, Zhai, Jiang (bib33) 2009; 10
Tattoli, Carneiro, Jéhanno, Magalhaes, Shu, Philpott, Arnoult, Girardin (bib26) 2008; 9
Komuro, Horvath (bib14) 2006; 80
Lechner, Malloth, Seppi, Beer, Jennings, Pfaller (bib17) 2008; 294
Venkataraman, Valdes, Elsby, Kakuta, Caceres, Saijo, Iwakura, Barber (bib28) 2007; 178
Allen, Scull, Moore, Holl, McElvania-TeKippe, Taxman, Guthrie, Pickles, Ting (bib2) 2009; 30
Rehwinkel, Tan, Goubau, Schulz, Pichlmair, Bier, Robb, Vreede, Barclay, Fodor, Reis e Sousa (bib22) 2010; 140
Moore, Bergstralh, Duncan, Lei, Morrison, Zimmermann, Accavitti-Loper, Madden, Sun, Ye (bib19) 2008; 451
Lich, Williams, Moore, Arthur, Davis, Taxman, Ting (bib18) 2007; 178
Abdul-Sater, Saïd-Sadier, Lam, Singh, Pettengill, Soares, Tattoli, Lipinski, Girardin, Rosenstiel, Ojcius (bib1) 2010; 285
Buchweitz, Harkema, Kaminski (bib5) 2007; 35
Sun, Sun, Liu, Chen, Seth, Forman, Chen (bib25) 2006; 24
Balachandran, Roberts, Kipperman, Bhalla, Compans, Archer, Barber (bib3) 2000; 74
Seth, Sun, Ea, Chen (bib24) 2005; 122
Kato, Sato, Yoneyama, Yamamoto, Uematsu, Matsui, Tsujimura, Takeda, Fujita, Takeuchi, Akira (bib11) 2005; 23
Le Goffic, Pothlichet, Vitour, Fujita, Meurs, Chignard, Si-Tahar (bib16) 2007; 178
Kato, Takeuchi, Sato, Yoneyama, Yamamoto, Matsui, Uematsu, Jung, Kawai, Ishii (bib12) 2006; 441
Hayman, Comely, Lackenby, Hartgroves, Goodbourn, McCauley, Barclay (bib8) 2007; 81
Jia, Song, Wei, Ni, Zheng, Xu, Ma, Li, Zhang, He (bib9) 2009; 183
Benko, Magalhaes, Philpott, Girardin (bib4) 2010; 185
Kawai, Takahashi, Sato, Coban, Kumar, Kato, Ishii, Takeuchi, Akira (bib13) 2005; 6
Jounai, Takeshita, Kobiyama, Sawano, Miyawaki, Xin, Ishii, Kawai, Akira, Suzuki, Okuda (bib10) 2007; 104
Xia, Cui, Wang, Zhu, Matsueda, Wang, Yang, Hong, Songyang, Chen, Wang (bib30) 2011; 34
Xu, Xiao, Liu, Ren, Gu (bib31) 2009; 106
Thomas, Dash, Aldridge, Ellebedy, Reynolds, Funk, Martin, Lamkanfi, Webby, Boyd (bib27) 2009; 30
Pichlmair, Schulz, Tan, Näslund, Liljeström, Weber, Reis e Sousa (bib21) 2006; 314
18200010 - Nature. 2008 Jan 31;451(7178):573-7
21703534 - Immunity. 2011 Jun 24;34(6):821-2
16713980 - Immunity. 2006 May;24(5):633-42
16127453 - Nat Immunol. 2005 Oct;6(10):981-8
17038589 - Science. 2006 Nov 10;314(5801):997-1001
17339430 - J Immunol. 2007 Mar 15;178(6):3368-72
18032529 - Am J Physiol Cell Physiol. 2008 Jan;294(1):C153-60
19701189 - Nat Immunol. 2009 Oct;10(10):1073-80
21703539 - Immunity. 2011 Jun 24;34(6):843-53
16625202 - Nature. 2006 May 4;441(7089):101-5
19164550 - Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1530-5
17237370 - J Immunol. 2007 Feb 1;178(3):1256-60
18219313 - EMBO Rep. 2008 Mar;9(3):293-300
20538593 - J Biol Chem. 2010 Aug 20;285(34):26223-32
17053203 - Am J Respir Cell Mol Biol. 2007 Mar;36(3):263-9
17487773 - Toxicol Pathol. 2007 Apr;35(3):424-35
20434986 - Cell. 2010 Apr 30;141(3):483-96
16203735 - J Biol Chem. 2005 Dec 2;280(48):39914-24
19690333 - Sci Signal. 2009;2(84):ra47
20610642 - J Immunol. 2010 Aug 1;185(3):1681-91
16039576 - Immunity. 2005 Jul;23(1):19-28
17020950 - J Virol. 2006 Dec;80(24):12332-42
17182679 - J Virol. 2007 Mar;81(5):2318-27
19881509 - Nat Immunol. 2009 Dec;10(12):1300-8
17475874 - J Immunol. 2007 May 15;178(10):6444-55
20061403 - J Immunol. 2010 Feb 15;184(4):1990-2000
19362020 - Immunity. 2009 Apr 17;30(4):556-65
16125763 - Cell. 2005 Sep 9;122(5):669-82
19362023 - Immunity. 2009 Apr 17;30(4):566-75
17709747 - Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14050-5
20144762 - Cell. 2010 Feb 5;140(3):397-408
20959452 - J Biol Chem. 2010 Dec 31;285(53):41637-45
10627563 - J Virol. 2000 Feb;74(3):1513-23
19734229 - J Immunol. 2009 Oct 1;183(7):4241-8
Venkataraman (10.1016/j.immuni.2011.03.026_bib28) 2007; 178
Abdul-Sater (10.1016/j.immuni.2011.03.026_bib1) 2010; 285
You (10.1016/j.immuni.2011.03.026_bib33) 2009; 10
Guo (10.1016/j.immuni.2011.03.026_bib7) 2007; 36
Xia (10.1016/j.immuni.2011.03.026_bib30) 2011; 34
Thomas (10.1016/j.immuni.2011.03.026_bib27) 2009; 30
Kawai (10.1016/j.immuni.2011.03.026_bib13) 2005; 6
Jounai (10.1016/j.immuni.2011.03.026_bib10) 2007; 104
Pichlmair (10.1016/j.immuni.2011.03.026_bib21) 2006; 314
Williams (10.1016/j.immuni.2011.03.026_bib29) 2005; 280
Allen (10.1016/j.immuni.2011.03.026_bib2) 2009; 30
Kato (10.1016/j.immuni.2011.03.026_bib12) 2006; 441
Lechner (10.1016/j.immuni.2011.03.026_bib17) 2008; 294
Seth (10.1016/j.immuni.2011.03.026_bib24) 2005; 122
Xu (10.1016/j.immuni.2011.03.026_bib31) 2009; 106
Balachandran (10.1016/j.immuni.2011.03.026_bib3) 2000; 74
Le Goffic (10.1016/j.immuni.2011.03.026_bib16) 2007; 178
Sabbah (10.1016/j.immuni.2011.03.026_bib23) 2009; 10
Yasukawa (10.1016/j.immuni.2011.03.026_bib32) 2009; 2
Kato (10.1016/j.immuni.2011.03.026_bib11) 2005; 23
Rehwinkel (10.1016/j.immuni.2011.03.026_bib22) 2010; 140
Tattoli (10.1016/j.immuni.2011.03.026_bib26) 2008; 9
Komuro (10.1016/j.immuni.2011.03.026_bib14) 2006; 80
Moore (10.1016/j.immuni.2011.03.026_bib19) 2008; 451
Jia (10.1016/j.immuni.2011.03.026_bib9) 2009; 183
Lich (10.1016/j.immuni.2011.03.026_bib18) 2007; 178
Benko (10.1016/j.immuni.2011.03.026_bib4) 2010; 185
Buchweitz (10.1016/j.immuni.2011.03.026_bib5) 2007; 35
Neerincx (10.1016/j.immuni.2011.03.026_bib20) 2010; 285
Cui (10.1016/j.immuni.2011.03.026_bib6) 2010; 141
Hayman (10.1016/j.immuni.2011.03.026_bib8) 2007; 81
Sun (10.1016/j.immuni.2011.03.026_bib25) 2006; 24
Kuenzel (10.1016/j.immuni.2011.03.026_bib15) 2010; 184
References_xml – volume: 451
  start-page: 573
  year: 2008
  end-page: 577
  ident: bib19
  article-title: NLRX1 is a regulator of mitochondrial antiviral immunity
  publication-title: Nature
  contributor:
    fullname: Ye
– volume: 10
  start-page: 1073
  year: 2009
  end-page: 1080
  ident: bib23
  article-title: Activation of innate immune antiviral responses by Nod2
  publication-title: Nat. Immunol.
  contributor:
    fullname: Bose
– volume: 185
  start-page: 1681
  year: 2010
  end-page: 1691
  ident: bib4
  article-title: NLRC5 limits the activation of inflammatory pathways
  publication-title: J. Immunol.
  contributor:
    fullname: Girardin
– volume: 178
  start-page: 1256
  year: 2007
  end-page: 1260
  ident: bib18
  article-title: Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes
  publication-title: J. Immunol.
  contributor:
    fullname: Ting
– volume: 30
  start-page: 556
  year: 2009
  end-page: 565
  ident: bib2
  article-title: The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA
  publication-title: Immunity
  contributor:
    fullname: Ting
– volume: 30
  start-page: 566
  year: 2009
  end-page: 575
  ident: bib27
  article-title: The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1
  publication-title: Immunity
  contributor:
    fullname: Boyd
– volume: 141
  start-page: 483
  year: 2010
  end-page: 496
  ident: bib6
  article-title: NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways
  publication-title: Cell
  contributor:
    fullname: Wang
– volume: 10
  start-page: 1300
  year: 2009
  end-page: 1308
  ident: bib33
  article-title: PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4
  publication-title: Nat. Immunol.
  contributor:
    fullname: Jiang
– volume: 122
  start-page: 669
  year: 2005
  end-page: 682
  ident: bib24
  article-title: Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3
  publication-title: Cell
  contributor:
    fullname: Chen
– volume: 34
  start-page: 843
  year: 2011
  end-page: 853
  ident: bib30
  article-title: NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK
  publication-title: Immunity
  contributor:
    fullname: Wang
– volume: 80
  start-page: 12332
  year: 2006
  end-page: 12342
  ident: bib14
  article-title: RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2
  publication-title: J. Virol.
  contributor:
    fullname: Horvath
– volume: 294
  start-page: C153
  year: 2008
  end-page: C160
  ident: bib17
  article-title: IFN-alpha induces barrier destabilization and apoptosis in renal proximal tubular epithelium
  publication-title: Am. J. Physiol. Cell Physiol.
  contributor:
    fullname: Pfaller
– volume: 285
  start-page: 26223
  year: 2010
  end-page: 26232
  ident: bib20
  article-title: A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Kufer
– volume: 280
  start-page: 39914
  year: 2005
  end-page: 39924
  ident: bib29
  article-title: The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Su
– volume: 314
  start-page: 997
  year: 2006
  end-page: 1001
  ident: bib21
  article-title: RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates
  publication-title: Science
  contributor:
    fullname: Reis e Sousa
– volume: 36
  start-page: 263
  year: 2007
  end-page: 269
  ident: bib7
  article-title: NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I
  publication-title: Am. J. Respir. Cell Mol. Biol.
  contributor:
    fullname: Sambhara
– volume: 178
  start-page: 3368
  year: 2007
  end-page: 3372
  ident: bib16
  article-title: Cutting edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells
  publication-title: J. Immunol.
  contributor:
    fullname: Si-Tahar
– volume: 23
  start-page: 19
  year: 2005
  end-page: 28
  ident: bib11
  article-title: Cell type-specific involvement of RIG-I in antiviral response
  publication-title: Immunity
  contributor:
    fullname: Akira
– volume: 24
  start-page: 633
  year: 2006
  end-page: 642
  ident: bib25
  article-title: The specific and essential role of MAVS in antiviral innate immune responses
  publication-title: Immunity
  contributor:
    fullname: Chen
– volume: 285
  start-page: 41637
  year: 2010
  end-page: 41645
  ident: bib1
  article-title: Enhancement of reactive oxygen species production and chlamydial infection by the mitochondrial Nod-like family member NLRX1
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Ojcius
– volume: 104
  start-page: 14050
  year: 2007
  end-page: 14055
  ident: bib10
  article-title: The Atg5 Atg12 conjugate associates with innate antiviral immune responses
  publication-title: Proc. Natl. Acad. Sci. USA
  contributor:
    fullname: Okuda
– volume: 35
  start-page: 424
  year: 2007
  end-page: 435
  ident: bib5
  article-title: Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice
  publication-title: Toxicol. Pathol.
  contributor:
    fullname: Kaminski
– volume: 106
  start-page: 1530
  year: 2009
  end-page: 1535
  ident: bib31
  article-title: Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria
  publication-title: Proc. Natl. Acad. Sci. USA
  contributor:
    fullname: Gu
– volume: 184
  start-page: 1990
  year: 2010
  end-page: 2000
  ident: bib15
  article-title: The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses
  publication-title: J. Immunol.
  contributor:
    fullname: Rosenstiel
– volume: 183
  start-page: 4241
  year: 2009
  end-page: 4248
  ident: bib9
  article-title: Negative regulation of MAVS-mediated innate immune response by PSMA7
  publication-title: J. Immunol.
  contributor:
    fullname: He
– volume: 441
  start-page: 101
  year: 2006
  end-page: 105
  ident: bib12
  article-title: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
  publication-title: Nature
  contributor:
    fullname: Ishii
– volume: 6
  start-page: 981
  year: 2005
  end-page: 988
  ident: bib13
  article-title: IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
  publication-title: Nat. Immunol.
  contributor:
    fullname: Akira
– volume: 81
  start-page: 2318
  year: 2007
  end-page: 2327
  ident: bib8
  article-title: NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response
  publication-title: J. Virol.
  contributor:
    fullname: Barclay
– volume: 2
  start-page: ra47
  year: 2009
  ident: bib32
  article-title: Mitofusin 2 inhibits mitochondrial antiviral signaling
  publication-title: Sci. Signal.
  contributor:
    fullname: Koshiba
– volume: 140
  start-page: 397
  year: 2010
  end-page: 408
  ident: bib22
  article-title: RIG-I detects viral genomic RNA during negative-strand RNA virus infection
  publication-title: Cell
  contributor:
    fullname: Reis e Sousa
– volume: 9
  start-page: 293
  year: 2008
  end-page: 300
  ident: bib26
  article-title: NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production
  publication-title: EMBO Rep.
  contributor:
    fullname: Girardin
– volume: 178
  start-page: 6444
  year: 2007
  end-page: 6455
  ident: bib28
  article-title: Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses
  publication-title: J. Immunol.
  contributor:
    fullname: Barber
– volume: 74
  start-page: 1513
  year: 2000
  end-page: 1523
  ident: bib3
  article-title: Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway
  publication-title: J. Virol.
  contributor:
    fullname: Barber
– volume: 178
  start-page: 6444
  year: 2007
  ident: 10.1016/j.immuni.2011.03.026_bib28
  article-title: Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.178.10.6444
  contributor:
    fullname: Venkataraman
– volume: 34
  start-page: 843
  year: 2011
  ident: 10.1016/j.immuni.2011.03.026_bib30
  article-title: NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK
  publication-title: Immunity
  doi: 10.1016/j.immuni.2011.02.022
  contributor:
    fullname: Xia
– volume: 2
  start-page: ra47
  year: 2009
  ident: 10.1016/j.immuni.2011.03.026_bib32
  article-title: Mitofusin 2 inhibits mitochondrial antiviral signaling
  publication-title: Sci. Signal.
  doi: 10.1126/scisignal.2000287
  contributor:
    fullname: Yasukawa
– volume: 36
  start-page: 263
  year: 2007
  ident: 10.1016/j.immuni.2011.03.026_bib7
  article-title: NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I
  publication-title: Am. J. Respir. Cell Mol. Biol.
  doi: 10.1165/rcmb.2006-0283RC
  contributor:
    fullname: Guo
– volume: 24
  start-page: 633
  year: 2006
  ident: 10.1016/j.immuni.2011.03.026_bib25
  article-title: The specific and essential role of MAVS in antiviral innate immune responses
  publication-title: Immunity
  doi: 10.1016/j.immuni.2006.04.004
  contributor:
    fullname: Sun
– volume: 285
  start-page: 26223
  year: 2010
  ident: 10.1016/j.immuni.2011.03.026_bib20
  article-title: A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110.109736
  contributor:
    fullname: Neerincx
– volume: 106
  start-page: 1530
  year: 2009
  ident: 10.1016/j.immuni.2011.03.026_bib31
  article-title: Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0811029106
  contributor:
    fullname: Xu
– volume: 451
  start-page: 573
  year: 2008
  ident: 10.1016/j.immuni.2011.03.026_bib19
  article-title: NLRX1 is a regulator of mitochondrial antiviral immunity
  publication-title: Nature
  doi: 10.1038/nature06501
  contributor:
    fullname: Moore
– volume: 6
  start-page: 981
  year: 2005
  ident: 10.1016/j.immuni.2011.03.026_bib13
  article-title: IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1243
  contributor:
    fullname: Kawai
– volume: 35
  start-page: 424
  year: 2007
  ident: 10.1016/j.immuni.2011.03.026_bib5
  article-title: Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice
  publication-title: Toxicol. Pathol.
  doi: 10.1080/01926230701302558
  contributor:
    fullname: Buchweitz
– volume: 122
  start-page: 669
  year: 2005
  ident: 10.1016/j.immuni.2011.03.026_bib24
  article-title: Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3
  publication-title: Cell
  doi: 10.1016/j.cell.2005.08.012
  contributor:
    fullname: Seth
– volume: 184
  start-page: 1990
  year: 2010
  ident: 10.1016/j.immuni.2011.03.026_bib15
  article-title: The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0900557
  contributor:
    fullname: Kuenzel
– volume: 140
  start-page: 397
  year: 2010
  ident: 10.1016/j.immuni.2011.03.026_bib22
  article-title: RIG-I detects viral genomic RNA during negative-strand RNA virus infection
  publication-title: Cell
  doi: 10.1016/j.cell.2010.01.020
  contributor:
    fullname: Rehwinkel
– volume: 185
  start-page: 1681
  year: 2010
  ident: 10.1016/j.immuni.2011.03.026_bib4
  article-title: NLRC5 limits the activation of inflammatory pathways
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0903900
  contributor:
    fullname: Benko
– volume: 183
  start-page: 4241
  year: 2009
  ident: 10.1016/j.immuni.2011.03.026_bib9
  article-title: Negative regulation of MAVS-mediated innate immune response by PSMA7
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0901646
  contributor:
    fullname: Jia
– volume: 441
  start-page: 101
  year: 2006
  ident: 10.1016/j.immuni.2011.03.026_bib12
  article-title: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
  publication-title: Nature
  doi: 10.1038/nature04734
  contributor:
    fullname: Kato
– volume: 81
  start-page: 2318
  year: 2007
  ident: 10.1016/j.immuni.2011.03.026_bib8
  article-title: NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response
  publication-title: J. Virol.
  doi: 10.1128/JVI.01856-06
  contributor:
    fullname: Hayman
– volume: 104
  start-page: 14050
  year: 2007
  ident: 10.1016/j.immuni.2011.03.026_bib10
  article-title: The Atg5 Atg12 conjugate associates with innate antiviral immune responses
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0704014104
  contributor:
    fullname: Jounai
– volume: 10
  start-page: 1300
  year: 2009
  ident: 10.1016/j.immuni.2011.03.026_bib33
  article-title: PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1815
  contributor:
    fullname: You
– volume: 74
  start-page: 1513
  year: 2000
  ident: 10.1016/j.immuni.2011.03.026_bib3
  article-title: Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway
  publication-title: J. Virol.
  doi: 10.1128/JVI.74.3.1513-1523.2000
  contributor:
    fullname: Balachandran
– volume: 280
  start-page: 39914
  year: 2005
  ident: 10.1016/j.immuni.2011.03.026_bib29
  article-title: The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M502820200
  contributor:
    fullname: Williams
– volume: 30
  start-page: 566
  year: 2009
  ident: 10.1016/j.immuni.2011.03.026_bib27
  article-title: The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1
  publication-title: Immunity
  doi: 10.1016/j.immuni.2009.02.006
  contributor:
    fullname: Thomas
– volume: 285
  start-page: 41637
  year: 2010
  ident: 10.1016/j.immuni.2011.03.026_bib1
  article-title: Enhancement of reactive oxygen species production and chlamydial infection by the mitochondrial Nod-like family member NLRX1
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110.137885
  contributor:
    fullname: Abdul-Sater
– volume: 314
  start-page: 997
  year: 2006
  ident: 10.1016/j.immuni.2011.03.026_bib21
  article-title: RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates
  publication-title: Science
  doi: 10.1126/science.1132998
  contributor:
    fullname: Pichlmair
– volume: 294
  start-page: C153
  year: 2008
  ident: 10.1016/j.immuni.2011.03.026_bib17
  article-title: IFN-alpha induces barrier destabilization and apoptosis in renal proximal tubular epithelium
  publication-title: Am. J. Physiol. Cell Physiol.
  doi: 10.1152/ajpcell.00120.2007
  contributor:
    fullname: Lechner
– volume: 9
  start-page: 293
  year: 2008
  ident: 10.1016/j.immuni.2011.03.026_bib26
  article-title: NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production
  publication-title: EMBO Rep.
  doi: 10.1038/sj.embor.7401161
  contributor:
    fullname: Tattoli
– volume: 80
  start-page: 12332
  year: 2006
  ident: 10.1016/j.immuni.2011.03.026_bib14
  article-title: RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2
  publication-title: J. Virol.
  doi: 10.1128/JVI.01325-06
  contributor:
    fullname: Komuro
– volume: 178
  start-page: 1256
  year: 2007
  ident: 10.1016/j.immuni.2011.03.026_bib18
  article-title: Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.178.3.1256
  contributor:
    fullname: Lich
– volume: 30
  start-page: 556
  year: 2009
  ident: 10.1016/j.immuni.2011.03.026_bib2
  article-title: The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA
  publication-title: Immunity
  doi: 10.1016/j.immuni.2009.02.005
  contributor:
    fullname: Allen
– volume: 178
  start-page: 3368
  year: 2007
  ident: 10.1016/j.immuni.2011.03.026_bib16
  article-title: Cutting edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.178.6.3368
  contributor:
    fullname: Le Goffic
– volume: 141
  start-page: 483
  year: 2010
  ident: 10.1016/j.immuni.2011.03.026_bib6
  article-title: NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways
  publication-title: Cell
  doi: 10.1016/j.cell.2010.03.040
  contributor:
    fullname: Cui
– volume: 23
  start-page: 19
  year: 2005
  ident: 10.1016/j.immuni.2011.03.026_bib11
  article-title: Cell type-specific involvement of RIG-I in antiviral response
  publication-title: Immunity
  doi: 10.1016/j.immuni.2005.04.010
  contributor:
    fullname: Kato
– volume: 10
  start-page: 1073
  year: 2009
  ident: 10.1016/j.immuni.2011.03.026_bib23
  article-title: Activation of innate immune antiviral responses by Nod2
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1782
  contributor:
    fullname: Sabbah
SSID ssj0014590
Score 2.5598629
Snippet The nucleotide-binding domain and leucine-rich-repeat-containing (NLR) proteins regulate innate immunity. Although the positive regulatory impact of NLRs is...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 854
SubjectTerms Adaptor Proteins, Signal Transducing - immunology
Adaptor Proteins, Signal Transducing - metabolism
Animals
Cells, Cultured
Influenza A Virus, H1N1 Subtype - immunology
Interferon-beta - biosynthesis
Interferon-beta - immunology
Interleukin-6 - biosynthesis
Interleukin-6 - immunology
Macrophages - immunology
Membrane Proteins - immunology
Membrane Proteins - metabolism
Mice
Mice, Knockout
Mitochondrial Proteins - deficiency
Mitochondrial Proteins - immunology
Nerve Tissue Proteins - immunology
Nerve Tissue Proteins - metabolism
NF-kappa B - immunology
NF-kappa B - metabolism
Orthomyxoviridae Infections - immunology
Signal Transduction
TNF Receptor-Associated Factor 6 - immunology
TNF Receptor-Associated Factor 6 - metabolism
Title NLRX1 Protein Attenuates Inflammatory Responses to Infection by Interfering with the RIG-I-MAVS and TRAF6-NF-κB Signaling Pathways
URI https://dx.doi.org/10.1016/j.immuni.2011.03.026
https://www.ncbi.nlm.nih.gov/pubmed/21703540
https://search.proquest.com/docview/874018156
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFD70wkZfRtfdsnVFD3vVItuKYj86pWmzNKE4bZc3IdlS8WBOaR1Gnvev9iP2m3Yk24HBxmBPBlnCQuf46DsXfQL4EOhhaAMWU2URvvGQ5VTnrKBWm0QPVMKYdgH92Vxc3PBPy8FyB067szCurLK1_Y1N99a6bem3q9m_L8v-wpUSohMeOdIzBBHRLuw7LnNU7f10dDu93CYT-CBh29JDHNCdoPNlXqU_htFyeUYfPcvCn3eovyFQvxOND-FZCyFJ2szyOeyY6gieNJdKbo7g6axNl7-A7_PLbBmQK8fFUFYkrREgrx24JJPKoip89Sl2kjV1sthcr9wbX51VEb0hPl5oPVshcRFbgnCRZJNzOqGz9HZBVFWQ6ywdCzof058_RmRR3jlkj92vEFp-U5vHl3AzPrs-vaDtrQs0R-euphEvONeR5hG3JmFaCTE0ikUWnQ-D7kjC4lwphFW6CIxNzJDpnNswFyqITcxV9Ar2qlVl3gBRgRiEJraFsOh14TBRMGHR6UEzy_M47wHtVlreN-Qasqs6-yIbyUgnGckiiZLpwbATh_xNSSTa_3-MJJ30JP4_LimiKrNaP0p_JaGjzOnB60aq26mgt8ZcWOztf3_2HRw0MWhBQ34Me_XD2rxHEFPrk1ZJ3XOafZ6ewO5kOfoF7l7yIg
link.rule.ids 314,780,784,3506,27569,27924,27925,45663,45874
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwED-NTTBeEAwY5a8feDV1YtdNHrOJ0rK2mtpu6ptlJzYKEunEUqE-8634EHwmzk5SCQmExKsTK5bvcv7d3e_OAG8jM4xdxBKqHcI3EbOcmpwV1BmbmoFOGTM-oD-by_GV-LgerA_gvKuF8bTK1vY3Nj1Y63ak3-5m_6Ys-0tPJUQnnPumZwgi-B04QjQgUdmPsrPri-k-mSAGKdtTD3FCV0EXaF5lKMNoe3nyd6HLwp9PqL8h0HASjR7CgxZCkqxZ5SM4sNUJ3G0uldydwL1Zmy5_DN_n08U6Ipe-F0NZkaxGgLz14JJMKoeq8CWk2Mmi4cnicL3xTwI7qyJmR0K80IVuhcRHbAnCRbKYfKATOsuul0RXBVktspGk8xH9-eOMLMtPHtnj65cILb_p3e0TuBq9X52PaXvrAs3RuaspF4UQhhvBhbMpM1rKodWMO3Q-LLojKUtyrRFWmSKyLrVDZnLh4lzqKLGJ0PwpHFabyj4DoiM5iG3iCunQ68JpsmDSodODZlbkSd4D2u20ummaa6iOdfZZNZJRXjKKcYWS6cGwE4f6TUkU2v9_zCSd9BT-Pz4poiu72d6qcCWhb5nTg9NGqvuloLfGfFjs-X9_9g0cj1ezqZpO5hcv4H4Tj5Y0Fi_hsP66ta8Q0NTmdauwvwAPjPJg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=NLRX1+Protein+Attenuates+Inflammatory+Responses+to+Infection+by+Interfering+with+the+RIG-I-MAVS+and+TRAF6-NF-%CE%BAB+Signaling+Pathways&rft.jtitle=Immunity+%28Cambridge%2C+Mass.%29&rft.au=Allen%2C+Irving%C2%A0C.&rft.au=Moore%2C+Chris%C2%A0B.&rft.au=Schneider%2C+Monika&rft.au=Lei%2C+Yu&rft.date=2011-06-24&rft.pub=Elsevier+Inc&rft.issn=1074-7613&rft.eissn=1097-4180&rft.volume=34&rft.issue=6&rft.spage=854&rft.epage=865&rft_id=info:doi/10.1016%2Fj.immuni.2011.03.026&rft.externalDocID=S1074761311002263
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1074-7613&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1074-7613&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1074-7613&client=summon